Ask Anything
Hot Research Today
Papers from every journal, all in one place. Create custom feeds.
RCT · n=2,50811 mentionsTrending on X
AUG 12JhanjiJAMA
Total intravenous anesthesia fails to improve days alive and at home versus inhalational anesthesia.
TIVA confers no recovery advantage over inhalational anesthesia; supports either approach in older adults undergoing major noncardiac surgery.
DBDr. Bernard
Anesthesiologist, Unknown
First of all, congratulations both to Joyce, Shaman, and the people group, you know, and the U.K. for actually executing this trial and recruiting. So it's a fabulous feat. I think as you said, it's absolutely a positive study... in the sense that it's reassuring that the techniques that are available to us as a community... it's absolutely reassuring that whatever anesthetic choice we have available to us, patients will do well.
cohort · n=4,1611 mentions
AUG 12Yoonnpj Digital Medicine
Sacubitril/valsartan linked to ~18% fewer major events vs. valsartan in a machine learning-identified HFpEF phenotype.
May support phenotype-guided sacubitril/valsartan in HFpEF; leaves open prospective validation before practice change.
cohort · n=1,1472 mentions
AUG 14EhrJACC Advances
Selective iliofemoral angiography after TF-TAVI shows similar vascular and access-site complications to routine angiography.
Selective angiography may suffice without excess major complications; leaves open whether routine use improves outcomes in randomized settings.
meta-analysis · n=10,1001 mentions
AUG 14BaeJournal of Clinical Medicine
CCTA-detected obstructive CAD is linked to ~618% higher perioperative MACE risk.
May enhance preoperative risk stratification with coronary CT; extends observational data but leaves open need for prospective validation.
systematic_review8 mentionsTrending on X
AUG 12Ibarra-PesoMedicina
Omega-3 supplementation yields mixed effects on arterial stiffness but reduces PWV at moderately high doses.
May support 1.8–4 g/day omega-3 for arterial stiffness reduction; extends meta-analyses by clarifying dose heterogeneity.
cohort · n=1,5382 mentionsTrending on XExpert Commentary
AUG 14OmoteJACC Advances
M-TEER in LVEF <20% does not increase 1-year death or HF hospitalization versus LVEF 20-40%.
Supports M-TEER feasibility in LVEF<20%; leaves open confirmation by randomized trials.
cohort · n=5,528,397Trending on XExpert Commentary
AUG 12KhanJACC Advances
Renal disease linked to ~39% higher 30-day readmission and increased mortality following AF hospitalization.
National AF hospitalization trends reported; leaves open causal factors and targeted interventions to reduce readmissions.
cohort · n=3081 mentions
AUG 13ParkJournal of Cardiovascular Electrophysiology
Powered rotational sheaths achieve similar success and major complication rates versus non-powered telescoping sheaths.
Observational comparison should not alter current TLE practice; leaves open randomized evaluation of rotational sheaths and WARD-10.
cohort · n=2341 mentions
AUG 14DoğanJournal of Cardiovascular Development and Disease
CCI and modified CCI fail to improve upon EuroSCORE II for predicting 30-day TAVI outcomes.
Comorbidity indices add nothing to EuroSCORE II for TAVI risk stratification; leaves open whether individual organ-reserve markers merit prospective testing.
systematic_review · n=322 mentionsTrending on X
AUG 14WuExpert Review of Pharmacoeconomics & Outcomes Research
Random forest and XGBoost dominate AI prediction of cardiovascular events in cancer despite methodological flaws.
May inform CV risk stratification in oncology; extends single-cancer AI reviews to diverse populations with clinical data.
